NEW YORK (Reuters Health) – Adding ramucirumab to paclitaxel as second-line therapy for advanced gastric cancer boosts progression-free survival (PFS)
Read moreHome »
No Drop in Intra-Abdominal Infectious Complications With Robotic Gastrectomy
NEW YORK (Reuters Health) – Robotic gastrectomy failed to reduce intra-abdominal infectious complications compared with standard laparoscopic gastrectomy in a
Read moreMetabolites in Plasma Could Serve as Biomarkers for Early Gastric Cancer
NEW YORK (Reuters Health) – Decreased plasma metabolite levels show promise as noninvasive biomarkers for early gastric cancer in high-risk
Read more